Ibogaline
Names | |
---|---|
IUPAC name
(1R,17S)-17-Ethyl-6,7-dimethoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4,6,8-tetraene
| |
Other names
12,13-Dimethoxyibogamine
| |
Identifiers | |
3D model (
JSmol ) |
|
ChemSpider | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
Properties | |
C21H28N2O2 | |
Molar mass | 340.467 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Ibogaline is an
Tabernaemontana australis[1] which shares similar ibogan-biosynthetic pathways. The percentage of ibogaline in T. iboga root bark is up to 15% TA with ibogaine constituting 80% of the alkaloids and ibogamine up to 5%.[2][3]
Chemistry
Derivatives
Kisantine and Gabonine are thought to be ibogaline's oxidation byproducts.[4]
Adverse effect
In rodents, ibogaline induces more body
harmala alkaloids evaluated in rats, the study authors found the following order of potency in causing tremors:[5]
- ED50 (μmol/kg, sc): tabernanthine (4.5) > ibogaline (7.6) > harmaline (12.8) > harmine (13.7) > ibogaine (34.8) > noribogaine (176.0)
A subsequent study confirmed these findings.[6]